Uncovering the mechanisms of Acinetobacter baumannii virulence.
Harding CM, Hennon SW, Feldman MF.
Nat Rev Microbiol. 2018 Feb;16(2):91-102. doi: 10.1038/nrmicro.2017.148. Epub 2017 Dec 18.
Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options.
Lee CR, Lee JH, Park M, Park KS, Bae IK, Kim YB, Cha CJ, Jeong BC, Lee SH.
Front Cell Infect Microbiol. 2017 Mar 13;7:55. doi: 10.3389/fcimb.2017.00055. eCollection 2017.
Acinetobacter baumannii: Virulence Strategies and Host Defense Mechanisms.
Tiku V.
DNA Cell Biol. 2022 Jan;41(1):43-48. doi: 10.1089/dna.2021.0588. Epub 2021 Dec 23.
Clinical relevance of the ESKAPE pathogens.
Pendleton JN, Gorman SP, Gilmore BF.
Expert Rev Anti Infect Ther. 2013 Mar;11(3):297-308. doi: 10.1586/eri.13.12.
An overview of Acinetobacter baumannii pathogenesis: Motility, adherence and biofilm formation.
Mea HJ, Yong PVC, Wong EH.
Microbiol Res. 2021 Jun;247:126722. doi: 10.1016/j.micres.2021.126722. Epub 2021 Feb 4.
Acinetobacter baumannii: A comprehensive review of global epidemiology, clinical implications, host interactions, mechanisms of antimicrobial resistance and mitigation strategies.
Sharma R, Lakhanpal D.
Microb Pathog. 2025 Jul;204:107605. doi: 10.1016/j.micpath.2025.107605. Epub 2025 Apr 16.
Genomic epidemiology and phylodynamics of Acinetobacter baumannii bloodstream isolates in China.
Luo Q, Chang M, Lu P, Guo Q, Jiang X, Xiao T, Zhang H, Ma Y, Zhang Y, Yu W, Zhang E, Chen Y, Shen P, Ji J, Ying C, Liu Z; BRICS Working Group; Zhu H, Xiao Y.
Nat Commun. 2025 Apr 14;16(1):3536. doi: 10.1038/s41467-025-58772-9.
Acinetobacter baumannii treatment strategies: a review of therapeutic challenges and considerations.
Kubin CJ, Garzia C, Uhlemann A-C.
Antimicrob Agents Chemother. 2025 Aug 6;69(8):e0106324. doi: 10.1128/aac.01063-24. Epub 2025 Jul 9.
Host-pathogen interactions in Acinetobacter baumannii infection: recent advances and future challenges.
Chen W.
Future Microbiol. 2020 Jul;15:841-845. doi: 10.2217/fmb-2020-0032. Epub 2020 Jul 13.
Treating multidrug-resistant Acinetobacter baumannii infection by blocking its virulence factors.
López-Rojas R, Smani Y, Pachón J.
Expert Rev Anti Infect Ther. 2013 Mar;11(3):231-3. doi: 10.1586/eri.13.11.
